ATE524561T1 - Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken - Google Patents

Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken

Info

Publication number
ATE524561T1
ATE524561T1 AT05733183T AT05733183T ATE524561T1 AT E524561 T1 ATE524561 T1 AT E524561T1 AT 05733183 T AT05733183 T AT 05733183T AT 05733183 T AT05733183 T AT 05733183T AT E524561 T1 ATE524561 T1 AT E524561T1
Authority
AT
Austria
Prior art keywords
immunoassay techniques
allergen response
microarray immunoassay
determining allergen
determining
Prior art date
Application number
AT05733183T
Other languages
English (en)
Inventor
Hugh Sampson
Wayne Shreffler
Kirsten Beyer
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE524561T1 publication Critical patent/ATE524561T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05733183T 2004-04-06 2005-03-22 Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken ATE524561T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55982504P 2004-04-06 2004-04-06
US62092304P 2004-10-21 2004-10-21
PCT/US2005/009567 WO2005100995A2 (en) 2004-04-06 2005-03-22 Methods of determining allergen response using microarray imminoassay techinques

Publications (1)

Publication Number Publication Date
ATE524561T1 true ATE524561T1 (de) 2011-09-15

Family

ID=35150593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05733183T ATE524561T1 (de) 2004-04-06 2005-03-22 Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken

Country Status (4)

Country Link
US (2) US20090111702A1 (de)
EP (1) EP1733234B1 (de)
AT (1) ATE524561T1 (de)
WO (1) WO2005100995A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1873010B (zh) * 2006-04-14 2010-04-07 中国科学院武汉植物园 利用花生Ara h3启动子转基因载体的制备方法及应用
EP2003452A1 (de) * 2007-06-11 2008-12-17 Universität für Bodenkultur Wien Verfahren zur Diagnose einer Allergie
WO2012129246A2 (en) * 2011-03-20 2012-09-27 The Regents Of The University Of Colorado, A Body Corporate Method for predicting severity of allergic reaction
WO2013025519A1 (en) * 2011-08-12 2013-02-21 Rutgers, The State University Of New Jersey High throughput sensitization detection devices and methods
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
JP6452718B2 (ja) * 2014-04-03 2019-01-16 ジェニスフィア・エルエルシー 食物アレルギーを検出するためのペプチド、試薬及び方法
WO2017186808A1 (en) * 2016-04-27 2017-11-02 Allergy Therapeutics (Uk) Limited Treatment of peanut allergy
CA3080601A1 (en) * 2017-11-02 2019-05-09 Aimmune Therapeutics, Inc. Methods of oral immunotherapy
AU2019274450A1 (en) * 2018-05-22 2020-10-29 AllerGenis LLC Peptides and methods for detecting peanut allergies
EP3836801A4 (de) 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. Orale erdnussimmuntherapie mit erhaltungsdosis
EP3897681A4 (de) 2018-12-20 2022-10-26 Société des Produits Nestlé S.A. Für orale immuntherapie gegen erdnuss anwendbarer dosierplan für versäumte dosen
JP7574222B2 (ja) 2019-05-10 2024-10-28 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ピーナツアレルギー患者の生活の質を改善するための方法
US20230003738A1 (en) * 2019-11-18 2023-01-05 Applied Medical Enzyme Research Institute Corporation Method for Collecting Data for Predicting Occurrence of Anaphylaxis
EP4069423B1 (de) * 2019-12-04 2026-03-04 Astraveus Mikrofluidische vorrichtung und verfahren zur verarbeitung von partikeln
EP4100057A4 (de) * 2020-02-06 2024-02-21 Allergenis LLC Tests zum detektieren von erdnussallergien
TWI896841B (zh) * 2021-01-21 2025-09-11 日商東麗股份有限公司 過敏原固定化擔體及過敏原特異性抗體的檢測方法
JP7796376B2 (ja) * 2021-03-31 2026-01-09 学校法人藤田学園 牛乳アレルギーの新規抗原
US20250342925A1 (en) * 2022-04-15 2025-11-06 Samsung Life Public Welfare Foundation Method for providing food allergy treatment service using oral immunotherapy, computer program stored in recording medium to implement method, and system
CN115999664A (zh) * 2023-02-08 2023-04-25 南京仁迈生物科技有限公司 一种基于数字微流控芯片的全血分离血浆的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US542225A (en) 1895-07-02 Machine for manufacture of paper boxes
US5428133A (en) * 1987-12-31 1995-06-27 Tanox Biosystems, Inc. Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
US5449669A (en) * 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
CA2241918C (en) * 1995-12-29 2008-12-02 University Of Arkansas Peanut allergens and methods
US5801273A (en) * 1996-08-21 1998-09-01 Twenty-First Century Research Corporation Methods and devices for controlling the reaction rate of a hydrocarbon to an intermediate oxidation product by pressure drop adjustments
US6306170B2 (en) * 1997-04-25 2001-10-23 Tegementa, L.L.C. Threaded fusion cage anchoring device and method
US6172213B1 (en) 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6504013B1 (en) * 2000-02-01 2003-01-07 Idexx Laboratories, Inc. Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
CN1286969C (zh) 1999-12-14 2006-11-29 热生物之星公司 多肽和抗原的稳定稀释剂
EP1195606A1 (de) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-Assay auf Basis von Mikroanordnungen
EP1390067A1 (de) * 2001-05-11 2004-02-25 Novartis AG Zusammensetzungen zur behandlung von ige-assoziierten krankheiten

Also Published As

Publication number Publication date
EP1733234B1 (de) 2011-09-14
US20150168389A1 (en) 2015-06-18
EP1733234A4 (de) 2008-05-07
US20090111702A1 (en) 2009-04-30
WO2005100995A2 (en) 2005-10-27
WO2005100995A3 (en) 2006-11-16
EP1733234A2 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
WO2007035633A3 (en) Screening assays and methods
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE343591T1 (de) Antagonist für die multimerisierung von hiv-1 vif-protein
ATE333094T1 (de) Verfahren zur herstellung von protein-beladenen mikropartikeln
ATE493656T1 (de) Verfahren zur diagnose von multipler sklerose
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
AT505372A3 (de) Verfahren zur quantitativen bestimmung von analyten mit einem testelement sowie testsystem und verwendung desselben
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
ATE376672T1 (de) Verfahren zur diagnose von multipler sklerose
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
EP4397681A4 (de) Antikörper, immobilisierte antikörper damit, antikörperzusammensetzung, reagens für immunologische messung, immunologisches messverfahren und verfahren zur verbesserung der antigenantwort von antikörpern
DE602005007817D1 (de) Analyse-Verfahren unter Verwendung von abgeschwächter Totalreflektion
DE602005015563D1 (de) Optisches verfahren zur bestimmung der verteilung von lipidpartikeln in einer probe
EP1861706A4 (de) Vorrichtungen und verfahren für analyttests mit eingebauter ergebnismitteilung unter verwendung erkennbarer symbole
ATE426807T1 (de) Proteomanalyse verfahren zum drogen vergleich
ATE437182T1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
EP3622289C0 (de) Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben
DE112005002199A5 (de) Verfahren und System zur Echtheitsbestimmung der individual-typischen Merkmale von Prüfobjekten
ATE530907T1 (de) Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor
DE502005000046D1 (de) Verfahren zur Bestimmung von defekten Aktoren einer Brennkraftmaschine
DE112006000481A5 (de) Verfahren zur Bestimmung der elastischen Verformung von Bauteilen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties